Show simple item record

dc.contributor.authorCarcaillon, Laureen
dc.contributor.authorGarcía-García, F. J.en
dc.contributor.authorTresguerres, J. A. F.en
dc.contributor.authorGutiérrez Avila, G.en
dc.contributor.authorKireev, R.en
dc.contributor.authorRodríguez-Mañas, Leocadioen
dc.date.accessioned2016-01-14T12:17:22Zen
dc.date.available2016-01-14T12:17:22Zen
dc.date.issued2012-08en
dc.identifier.citationCarcaillon, L. et al (2012) 'Higher levels of endogenous estradiol are associated with frailty in postmenopausal women from the toledo study for healthy aging' J. Clin. Endocrinol. Metab. 97 (8):2898-906en
dc.identifier.issn1945-7197en
dc.identifier.pmid22679065en
dc.identifier.doi10.1210/jc.2012-1271en
dc.identifier.urihttp://hdl.handle.net/10547/593449en
dc.description.abstractAdverse effects of higher endogenous estradiol (E2) levels on various clinical outcomes and on determinants of the frailty syndrome have recently been reported. However, there are no data about the potential relationship between E2 and frailty. We aimed to study the association between E2 levels and frailty among older postmenopausal women not taking hormonal therapy.
dc.language.isoenen
dc.publisherEndocrine Societyen
dc.relation.urlhttp://press.endocrine.org/doi/abs/10.1210/jc.2012-1271en
dc.subjectendogenous estradiolen
dc.subjectToledo Study for Healthy Agingen
dc.subjectageingen
dc.subjectpostmenopausal womenen
dc.subject.meshAgeden
dc.subject.meshC-Reactive Proteinen
dc.subject.meshCohort Studiesen
dc.subject.meshEstradiolen
dc.subject.meshFemaleen
dc.subject.meshFrail Elderlyen
dc.subject.meshHumansen
dc.subject.meshPostmenopauseen
dc.titleHigher levels of endogenous estradiol are associated with frailty in postmenopausal women from the Toledo study for healthy agingen
dc.typeArticleen
dc.contributor.departmentHospital Universitario de Getafe, Toledoen
dc.identifier.journalThe Journal of clinical endocrinology and metabolismen
html.description.abstractAdverse effects of higher endogenous estradiol (E2) levels on various clinical outcomes and on determinants of the frailty syndrome have recently been reported. However, there are no data about the potential relationship between E2 and frailty. We aimed to study the association between E2 levels and frailty among older postmenopausal women not taking hormonal therapy.


This item appears in the following Collection(s)

Show simple item record